These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 18647634)

  • 41. Influenza vaccination coverage among Spanish children, 2006.
    Lopez-de-Andres A; Hernández-Barrera V; Carrasco-Garrido P; Gil-de-Miguel A; Jiménez-García R
    Public Health; 2009 Jul; 123(7):465-9. PubMed ID: 19535118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales.
    Jit M; Cromer D; Baguelin M; Stowe J; Andrews N; Miller E
    Vaccine; 2010 Dec; 29(1):115-22. PubMed ID: 21055501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Under-explored assumptions in influenza vaccination models: implications for the universal vaccination of children.
    Newall AT; Dehollain JP; Wood JG
    Vaccine; 2012 Aug; 30(39):5776-81. PubMed ID: 22789505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A method for estimating vaccine-preventable pediatric influenza pneumonia hospitalizations in developing countries: Thailand as a case study.
    Dawood FS; Fry AM; Muangchana C; Sanasuttipun W; Baggett HC; Chunsuttiwat S; Maloney SA; Simmerman JM
    Vaccine; 2011 Jun; 29(26):4416-21. PubMed ID: 21496470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct and indirect impact of influenza vaccination of young children on school absenteeism.
    King JC; Beckett D; Snyder J; Cummings GE; King BS; Magder LS
    Vaccine; 2012 Jan; 30(2):289-93. PubMed ID: 22085547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influenza vaccination coverages among children, adults, health care workers and immigrants in Spain: related factors and trends, 2003-2006.
    Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; López de Andrés A; Pérez N; de Miguel AG
    J Infect; 2008 Dec; 57(6):472-80. PubMed ID: 19010553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales.
    Atchison C; Lopman B; Edmunds WJ
    Vaccine; 2010 Apr; 28(18):3118-26. PubMed ID: 20197142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit.
    Lewis EN; Griffin MR; Szilagyi PG; Zhu Y; Edwards KM; Poehling KA
    Pediatrics; 2007 Sep; 120(3):467-72. PubMed ID: 17766517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seasonal influenza: an overview.
    Li C; Freedman M
    J Sch Nurs; 2009 Feb; 25 Suppl 1():4S-12S. PubMed ID: 19197008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influenza vaccine uptake and distribution in England and Wales using data from the General Practice Research Database, 1989/90-2003/04.
    Joseph C; Goddard N; Gelb D
    J Public Health (Oxf); 2005 Dec; 27(4):371-7. PubMed ID: 16207735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development, theoretical framework, and lessons learned from implementation of a school-based influenza vaccination intervention.
    Painter JE; Sales JM; Pazol K; Grimes T; Wingood GM; DiClemente RJ
    Health Promot Pract; 2010 May; 11(3 Suppl):42S-52S. PubMed ID: 20488968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influenza vaccination coverage among children with high-risk medical conditions.
    Esposito S; Marchisio P; Droghetti R; Lambertini L; Faelli N; Bosis S; Tosi S; Begliatti E; Principi N
    Vaccine; 2006 Jun; 24(24):5251-5. PubMed ID: 16621177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing influenza vaccine distribution.
    Medlock J; Galvani AP
    Science; 2009 Sep; 325(5948):1705-8. PubMed ID: 19696313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.
    Vesikari T; Groth N; Karvonen A; Borkowski A; Pellegrini M
    Vaccine; 2009 Oct; 27(45):6291-5. PubMed ID: 19840662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.
    Blank PR; Schwenkglenks M; Szucs TD
    J Infect; 2009 Jun; 58(6):446-58. PubMed ID: 19446340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long time trends in influenza-like illness and associated determinants in The Netherlands.
    Dijkstra F; Donker GA; Wilbrink B; Van Gageldonk-Lafeber AB; Van Der Sande MA
    Epidemiol Infect; 2009 Apr; 137(4):473-9. PubMed ID: 18789176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.